Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 98

    1.

    Salivary VEGF: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication.

    Upile T, Jerjes W, Kafas P, Harini S, Singh SU, Guyer M, Bentley M, Sudhoff H, Hopper C.

    Int Arch Med. 2009 Apr 24;2(1):12.

    PMID:
    19393057
    [PubMed]
    Free PMC Article
    2.

    Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis?

    Dunst J, Pigorsch S, Hänsgen G, Hintner I, Lautenschläger C, Becker A.

    Strahlenther Onkol. 1999 Mar;175(3):93-6.

    PMID:
    10093609
    [PubMed - indexed for MEDLINE]
    3.

    Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.

    Shang ZJ, Li JR, Li ZB.

    Int J Oral Maxillofac Surg. 2002 Oct;31(5):495-8.

    PMID:
    12418564
    [PubMed - indexed for MEDLINE]
    4.

    The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.

    Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.

    J Pathol. 2003 Jun;200(2):183-94.

    PMID:
    12754739
    [PubMed - indexed for MEDLINE]
    5.

    Serum levels of vascular endothelial growth factor in patients with head and neck cancer.

    Riedel F, Götte K, Schwalb J, Wirtz H, Bergler W, Hörmann K.

    Eur Arch Otorhinolaryngol. 2000;257(6):332-6.

    PMID:
    10993554
    [PubMed - indexed for MEDLINE]
    6.

    Vascular endothelial growth factor in normal human salivary glands and saliva: a possible role in the maintenance of mucosal homeostasis.

    Taichman NS, Cruchley AT, Fletcher LM, Hagi-Pavli EP, Paleolog EM, Abrams WR, Booth V, Edwards RM, Malamud D.

    Lab Invest. 1998 Jul;78(7):869-75.

    PMID:
    9690564
    [PubMed - indexed for MEDLINE]
    7.

    Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer.

    Duque JL, Loughlin KR, Adam RM, Kantoff PW, Zurakowski D, Freeman MR.

    Urology. 1999 Sep;54(3):523-7.

    PMID:
    10475365
    [PubMed - indexed for MEDLINE]
    8.

    Effect of multimodality therapy on circulating vascular endothelial growth factor levels in patients with oesophageal cancer.

    McDonnell CO, Harmey JH, Bouchier-Hayes DJ, Walsh TN.

    Br J Surg. 2001 Aug;88(8):1105-9.

    PMID:
    11488797
    [PubMed - indexed for MEDLINE]
    9.

    Salivary levels of vascular endothelial growth factor (VEGF) in recurrent aphthous ulceration.

    Brozovic S, Vucicevic-Boras V, Mravak-Stipetic M, Jukic S, Kleinheinz J, Lukac J.

    J Oral Pathol Med. 2002 Feb;31(2):106-8.

    PMID:
    11896832
    [PubMed - indexed for MEDLINE]
    10.

    Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.

    Salven P, Heikkilä P, Anttonen A, Kajanti M, Joensuu H.

    Mod Pathol. 1997 Nov;10(11):1128-33.

    PMID:
    9388064
    [PubMed - indexed for MEDLINE]
    11.

    Role of angiogenic factors: coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma.

    Eisma RJ, Spiro JD, Kreutzer DL.

    Laryngoscope. 1999 May;109(5):687-93.

    PMID:
    10334214
    [PubMed - indexed for MEDLINE]
    12.

    Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals.

    Pammer J, Weninger W, Mildner M, Burian M, Wojta J, Tschachler E.

    J Pathol. 1998 Oct;186(2):186-91.

    PMID:
    9924435
    [PubMed - indexed for MEDLINE]
    14.

    Tumor hypoxia and systemic levels of vascular endothelial growth factor (VEGF) in head and neck cancers.

    Dunst J, Stadler P, Becker A, Kuhnt T, Lautenschläger C, Molls M, Haensgen G.

    Strahlenther Onkol. 2001 Sep;177(9):469-73.

    PMID:
    11591020
    [PubMed - indexed for MEDLINE]
    15.

    Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?

    Dosquet C, Coudert MC, Lepage E, Cabane J, Richard F.

    Clin Cancer Res. 1997 Dec;3(12 Pt 1):2451-8.

    PMID:
    9815646
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Serum vascular endothelial growth factor levels correlate better with tumour stage in small cell lung cancer than albumin, neuron-specific enolase or lactate dehydrogenase.

    Mall JW, Schwenk W, Philipp AW, Meyer-Kipker C, Mall W, Muller J, Pollmann C.

    Respirology. 2002 Jun;7(2):99-102.

    PMID:
    11985730
    [PubMed - indexed for MEDLINE]
    17.

    Vascular endothelial growth factor expression in head and neck squamous cell carcinoma.

    Eisma RJ, Spiro JD, Kreutzer DL.

    Am J Surg. 1997 Nov;174(5):513-7.

    PMID:
    9374227
    [PubMed - indexed for MEDLINE]
    18.

    Anti-angiogenic activity of melatonin in advanced cancer patients.

    Lissoni P, Rovelli F, Malugani F, Bucovec R, Conti A, Maestroni GJ.

    Neuro Endocrinol Lett. 2001;22(1):45-7.

    PMID:
    11335879
    [PubMed - indexed for MEDLINE]
    20.

    Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients.

    Dirix LY, Vermeulen PB, Pawinski A, Prové A, Benoy I, De Pooter C, Martin M, Van Oosterom AT.

    Br J Cancer. 1997;76(2):238-43.

    PMID:
    9231925
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk